Filing search / Current reports / Quantum BioPharma Ltd / Page 2

6-K

xxbnlpsc

8 Jul 24

Amended and Restated Material Change Report

3:20pm

6-K

y0un1fk

28 Jun 24

FSD Pharma provides Corporate Update

5:01pm

6-K

su0f5e 6eh9ez1vs

28 Jun 24

Current report (foreign)

7:49am

6-K

keaomm4 3v2oqu

27 Jun 24

Current report (foreign)

7:34am

6-K

h21d6 hicq

13 Jun 24

Current report (foreign)

7:31am

6-K

fhk6 athjqqamk6gojs0

4 Jun 24

FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd™ in Acute Alcohol Intoxication

8:28am

6-K

8dv lw1ehvfleakg7

31 May 24

Current report (foreign)

7:30am

6-K

cgku4qreo qasdjz64

28 May 24

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd™ in Acute Alcohol Intoxication

8:15am

6-K

8iy jh0so

24 May 24

FSD Pharma Provides Corporate Update

4:51pm

6-K

5q8brwwssdd 1isf1t

16 May 24

Current report (foreign)

8:01am

6-K

4myj9hxe0lcled 8f9

15 May 24

Condensed consolidated interim financial statements

6:02am

6-K

m2l5o scfdr7cc

7 May 24

Current report (foreign)

8:31am

6-K

44974z dmwkt

30 Apr 24

Current report (foreign)

8:33am

6-K

1ggj4

25 Apr 24

Current report (foreign)

7:49am

6-K

pilzno

22 Apr 24

Current report (foreign)

8:01am

6-K

bvrbdy0zvs8ezl

17 Apr 24

Current report (foreign)

8:01am

6-K

vuk60 afec7

15 Apr 24

FSD Pharma announces Filing of Year-End 2023 Results

6:48pm

6-K

q9uunwj1s6 lfjw1t2qe

15 Apr 24

Current report (foreign)

8:03am

6-K

41w n77vwf

9 Apr 24

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

4:57pm

6-K

wfes2t

27 Mar 24

Current report (foreign)

8:01am